PLOS Global Public Health (Jan 2024)

Discontinuation of tenofovir disoproxil fumarate from initial ART regimens because of renal adverse events: An analysis of data from four multi-country clinical trials

  • McNeil Ngongondo,
  • Justin Ritz,
  • Michael D. Hughes,
  • Mitch Matoga,
  • Mina C. Hosseinipour

Journal volume & issue
Vol. 4, no. 1

Abstract

Read online

No abstracts available.